Genevieve Sparagna
Concepts (353)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiolipins | 37 | 2025 | 85 | 4.350 |
Why?
| | Myocardium | 22 | 2025 | 1002 | 2.030 |
Why?
| | Mitochondria, Heart | 18 | 2022 | 102 | 1.650 |
Why?
| | Mitochondria | 20 | 2025 | 948 | 1.190 |
Why?
| | Phospholipids | 11 | 2024 | 223 | 0.930 |
Why?
| | Acyltransferases | 12 | 2025 | 57 | 0.890 |
Why?
| | Heart Failure | 12 | 2016 | 2236 | 0.770 |
Why?
| | Barth Syndrome | 4 | 2022 | 8 | 0.750 |
Why?
| | Linoleic Acid | 6 | 2023 | 43 | 0.730 |
Why?
| | Fatty Acids | 11 | 2025 | 443 | 0.610 |
Why?
| | Myocytes, Cardiac | 7 | 2022 | 526 | 0.540 |
Why?
| | Rats | 26 | 2022 | 5647 | 0.490 |
Why?
| | Palmitic Acid | 4 | 2004 | 41 | 0.490 |
Why?
| | Electron Transport Complex III | 7 | 2017 | 16 | 0.490 |
Why?
| | Mitochondria, Liver | 6 | 2017 | 73 | 0.480 |
Why?
| | Diet, High-Fat | 4 | 2021 | 247 | 0.470 |
Why?
| | Animal Feed | 2 | 2013 | 53 | 0.410 |
Why?
| | Animals | 51 | 2025 | 36940 | 0.410 |
Why?
| | Rats, Inbred SHR | 9 | 2013 | 45 | 0.410 |
Why?
| | Apoptosis | 8 | 2009 | 2553 | 0.410 |
Why?
| | Reactive Oxygen Species | 4 | 2025 | 622 | 0.370 |
Why?
| | Berberine | 2 | 2021 | 6 | 0.360 |
Why?
| | Hypertrophy, Left Ventricular | 3 | 2009 | 131 | 0.360 |
Why?
| | Mitochondrial Trifunctional Protein, alpha Subunit | 2 | 2025 | 3 | 0.360 |
Why?
| | Mitochondria, Muscle | 2 | 2025 | 116 | 0.350 |
Why?
| | Liver | 5 | 2024 | 1943 | 0.350 |
Why?
| | Electron Transport Complex IV | 4 | 2012 | 60 | 0.340 |
Why?
| | Calcium | 9 | 2010 | 1199 | 0.330 |
Why?
| | Phospholipases A2, Calcium-Independent | 1 | 2009 | 5 | 0.320 |
Why?
| | Cardiomyopathies | 2 | 2025 | 350 | 0.320 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2021 | 142 | 0.310 |
Why?
| | Energy Metabolism | 4 | 2025 | 922 | 0.300 |
Why?
| | Fundulidae | 2 | 2018 | 2 | 0.300 |
Why?
| | Myocardial Reperfusion Injury | 3 | 2013 | 135 | 0.290 |
Why?
| | Saccharomyces cerevisiae | 3 | 2023 | 557 | 0.290 |
Why?
| | Mitochondrial Membranes | 3 | 2025 | 39 | 0.270 |
Why?
| | Ischemia | 4 | 2024 | 409 | 0.270 |
Why?
| | Diet | 3 | 2023 | 1278 | 0.270 |
Why?
| | Oxidation-Reduction | 11 | 2021 | 1060 | 0.270 |
Why?
| | Dietary Fats | 5 | 2023 | 304 | 0.270 |
Why?
| | Mitochondrial Trifunctional Protein | 2 | 2025 | 5 | 0.260 |
Why?
| | Diabetes, Gestational | 2 | 2021 | 318 | 0.260 |
Why?
| | Enzyme Inhibitors | 5 | 2013 | 840 | 0.260 |
Why?
| | Acclimatization | 2 | 2018 | 177 | 0.260 |
Why?
| | Oligopeptides | 2 | 2025 | 271 | 0.260 |
Why?
| | Electron Transport Complex I | 3 | 2021 | 41 | 0.250 |
Why?
| | Mitochondrial Membrane Transport Proteins | 4 | 2010 | 43 | 0.250 |
Why?
| | Rats, Sprague-Dawley | 10 | 2009 | 2486 | 0.250 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2012 | 180 | 0.250 |
Why?
| | Disease | 1 | 2006 | 98 | 0.240 |
Why?
| | Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase | 1 | 2025 | 3 | 0.240 |
Why?
| | Heart | 4 | 2017 | 655 | 0.240 |
Why?
| | Purpura | 1 | 2025 | 17 | 0.240 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2025 | 19 | 0.230 |
Why?
| | Docosahexaenoic Acids | 3 | 2017 | 84 | 0.230 |
Why?
| | Transcription Factors | 6 | 2022 | 1719 | 0.230 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2023 | 405 | 0.230 |
Why?
| | Mice, Inbred C57BL | 7 | 2025 | 5757 | 0.220 |
Why?
| | Body Weight | 6 | 2021 | 985 | 0.200 |
Why?
| | Cardiomyopathy, Dilated | 3 | 2014 | 385 | 0.200 |
Why?
| | Glutathione | 1 | 2024 | 356 | 0.190 |
Why?
| | Escherichia coli Proteins | 1 | 2024 | 200 | 0.190 |
Why?
| | Mice | 14 | 2025 | 17787 | 0.190 |
Why?
| | Fatty Acids, Unsaturated | 3 | 2021 | 99 | 0.180 |
Why?
| | Mitochondrial Diseases | 1 | 2022 | 91 | 0.180 |
Why?
| | Heart Diseases | 2 | 2021 | 346 | 0.180 |
Why?
| | Palmitates | 1 | 2000 | 18 | 0.170 |
Why?
| | Cytochrome c Group | 4 | 2001 | 43 | 0.170 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4295 | 0.170 |
Why?
| | Coenzyme A | 1 | 2020 | 7 | 0.170 |
Why?
| | Male | 27 | 2025 | 67762 | 0.170 |
Why?
| | Lipid Metabolism | 3 | 2020 | 518 | 0.170 |
Why?
| | Maternal-Fetal Exchange | 1 | 2021 | 165 | 0.170 |
Why?
| | B-Lymphocytes | 2 | 2022 | 847 | 0.160 |
Why?
| | Vascular Remodeling | 1 | 2022 | 193 | 0.160 |
Why?
| | Ethanol | 1 | 2004 | 608 | 0.160 |
Why?
| | Heart Ventricles | 3 | 2020 | 788 | 0.160 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 278 | 0.150 |
Why?
| | Animals, Newborn | 6 | 2022 | 844 | 0.150 |
Why?
| | Multienzyme Complexes | 2 | 2012 | 68 | 0.150 |
Why?
| | Physical Conditioning, Animal | 3 | 2008 | 257 | 0.150 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 363 | 0.150 |
Why?
| | Dietary Supplements | 2 | 2021 | 561 | 0.140 |
Why?
| | Thermotolerance | 1 | 2018 | 9 | 0.140 |
Why?
| | Cells, Cultured | 8 | 2021 | 4193 | 0.140 |
Why?
| | Disease Susceptibility | 1 | 2020 | 347 | 0.140 |
Why?
| | Islets of Langerhans | 2 | 2021 | 803 | 0.140 |
Why?
| | Optic Atrophy, Autosomal Dominant | 1 | 2017 | 1 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 248 | 0.140 |
Why?
| | Dynamins | 1 | 2017 | 37 | 0.140 |
Why?
| | Intermittent Claudication | 1 | 2018 | 118 | 0.140 |
Why?
| | Eicosapentaenoic Acid | 3 | 2017 | 39 | 0.140 |
Why?
| | Mitochondrial Dynamics | 1 | 2017 | 39 | 0.140 |
Why?
| | Muscle, Skeletal | 2 | 2025 | 1724 | 0.130 |
Why?
| | Phosphatidylglycerols | 2 | 2023 | 24 | 0.130 |
Why?
| | A Kinase Anchor Proteins | 1 | 2017 | 72 | 0.130 |
Why?
| | Biological Transport | 6 | 2024 | 418 | 0.130 |
Why?
| | Mitochondrial Proteins | 2 | 2016 | 257 | 0.130 |
Why?
| | Phenotype | 3 | 2022 | 3196 | 0.130 |
Why?
| | Kidney | 1 | 2024 | 1468 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2024 | 815 | 0.130 |
Why?
| | Blood Pressure | 7 | 2013 | 1786 | 0.120 |
Why?
| | Hypertension | 4 | 2008 | 1295 | 0.120 |
Why?
| | Sirtuins | 1 | 2016 | 40 | 0.120 |
Why?
| | Signal Transduction | 5 | 2021 | 5079 | 0.120 |
Why?
| | Gene Expression | 4 | 2021 | 1502 | 0.120 |
Why?
| | Electron Transport | 4 | 2021 | 115 | 0.120 |
Why?
| | Temperature | 1 | 2018 | 679 | 0.120 |
Why?
| | Huntington Disease | 1 | 2016 | 57 | 0.120 |
Why?
| | Female | 17 | 2022 | 73304 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 465 | 0.110 |
Why?
| | Caspases | 4 | 2013 | 247 | 0.110 |
Why?
| | Linoleoyl-CoA Desaturase | 1 | 2013 | 3 | 0.110 |
Why?
| | Fatty Liver | 1 | 2016 | 243 | 0.110 |
Why?
| | Spectrometry, Fluorescence | 1 | 1994 | 168 | 0.100 |
Why?
| | Lymphocytes | 1 | 2016 | 397 | 0.100 |
Why?
| | Mice, Transgenic | 4 | 2021 | 2167 | 0.100 |
Why?
| | Oleic Acid | 3 | 2022 | 40 | 0.100 |
Why?
| | Cell Differentiation | 1 | 2021 | 1991 | 0.100 |
Why?
| | Aging | 3 | 2008 | 1864 | 0.100 |
Why?
| | Oxidative Stress | 3 | 2025 | 1317 | 0.100 |
Why?
| | Safflower Oil | 1 | 2012 | 5 | 0.100 |
Why?
| | Lysophospholipids | 2 | 2012 | 80 | 0.100 |
Why?
| | Citrate (si)-Synthase | 3 | 2007 | 60 | 0.090 |
Why?
| | Echocardiography | 5 | 2020 | 642 | 0.090 |
Why?
| | Peripheral Arterial Disease | 1 | 2018 | 475 | 0.090 |
Why?
| | Humans | 20 | 2025 | 137585 | 0.090 |
Why?
| | Electron Transport Complex II | 1 | 2011 | 26 | 0.090 |
Why?
| | Time Factors | 4 | 2009 | 6828 | 0.090 |
Why?
| | Myocardial Contraction | 1 | 2013 | 341 | 0.090 |
Why?
| | Cryoelectron Microscopy | 1 | 2012 | 190 | 0.090 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2011 | 145 | 0.090 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2001 | 46 | 0.090 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2011 | 137 | 0.080 |
Why?
| | Nutritional Status | 1 | 2013 | 350 | 0.080 |
Why?
| | Mass Spectrometry | 3 | 2017 | 739 | 0.080 |
Why?
| | Ceramides | 2 | 2001 | 118 | 0.080 |
Why?
| | Tissue Survival | 1 | 2009 | 18 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2111 | 0.080 |
Why?
| | Fish Oils | 1 | 2009 | 26 | 0.080 |
Why?
| | Diacylglycerol Cholinephosphotransferase | 1 | 2008 | 1 | 0.080 |
Why?
| | Cytidine Diphosphate Diglycerides | 1 | 2008 | 3 | 0.080 |
Why?
| | Transferases (Other Substituted Phosphate Groups) | 1 | 2008 | 3 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2013 | 354 | 0.080 |
Why?
| | Phosphatidic Acids | 1 | 2008 | 9 | 0.080 |
Why?
| | Glycochenodeoxycholic Acid | 1 | 2008 | 14 | 0.080 |
Why?
| | Glycolysis | 2 | 2024 | 321 | 0.070 |
Why?
| | Cardiotonic Agents | 1 | 2009 | 124 | 0.070 |
Why?
| | alpha-Tocopherol | 1 | 2008 | 33 | 0.070 |
Why?
| | Rats, Inbred Strains | 1 | 2008 | 362 | 0.070 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2009 | 140 | 0.070 |
Why?
| | Superoxides | 2 | 2009 | 202 | 0.070 |
Why?
| | Adenosine Triphosphate | 3 | 2016 | 491 | 0.070 |
Why?
| | Cytosol | 2 | 2000 | 226 | 0.070 |
Why?
| | Molecular Structure | 1 | 2009 | 489 | 0.070 |
Why?
| | Calcium-Binding Proteins | 4 | 2008 | 218 | 0.070 |
Why?
| | Rats, Wistar | 3 | 2017 | 455 | 0.070 |
Why?
| | Blotting, Western | 4 | 2016 | 1226 | 0.070 |
Why?
| | Rats, Inbred BN | 1 | 2007 | 58 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 437 | 0.070 |
Why?
| | Antioxidants | 3 | 2025 | 584 | 0.070 |
Why?
| | Phosphatidylethanolamines | 2 | 2017 | 77 | 0.070 |
Why?
| | Obesity | 2 | 2021 | 2992 | 0.070 |
Why?
| | Membrane Potentials | 2 | 2000 | 284 | 0.070 |
Why?
| | Heart Function Tests | 2 | 2020 | 59 | 0.070 |
Why?
| | Phosphatidylcholines | 2 | 2017 | 147 | 0.060 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2006 | 24 | 0.060 |
Why?
| | Cardiac Output, Low | 1 | 2006 | 66 | 0.060 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 145 | 0.060 |
Why?
| | Stress, Physiological | 1 | 2009 | 443 | 0.060 |
Why?
| | Hypothyroidism | 1 | 2006 | 72 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2757 | 0.060 |
Why?
| | Syndrome | 1 | 2006 | 358 | 0.060 |
Why?
| | Mitochondrial Myopathies | 1 | 2025 | 9 | 0.060 |
Why?
| | Chromatography, Gas | 1 | 2005 | 33 | 0.060 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2025 | 72 | 0.060 |
Why?
| | Rhabdomyolysis | 1 | 2025 | 21 | 0.060 |
Why?
| | RNA, Messenger | 3 | 2020 | 2833 | 0.060 |
Why?
| | Cyclosporine | 2 | 2009 | 268 | 0.060 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2005 | 132 | 0.060 |
Why?
| | Enzyme Activation | 2 | 2012 | 810 | 0.060 |
Why?
| | Phospholipid Transfer Proteins | 1 | 2024 | 11 | 0.060 |
Why?
| | Escherichia coli K12 | 1 | 2024 | 7 | 0.060 |
Why?
| | Reference Standards | 1 | 2005 | 186 | 0.060 |
Why?
| | Protein Kinase C-epsilon | 1 | 2004 | 25 | 0.060 |
Why?
| | Pregnancy | 3 | 2022 | 6763 | 0.060 |
Why?
| | Linoleic Acids | 1 | 2023 | 7 | 0.050 |
Why?
| | Membrane Proteins | 2 | 2008 | 1164 | 0.050 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2007 | 382 | 0.050 |
Why?
| | Cell Respiration | 2 | 2017 | 103 | 0.050 |
Why?
| | Oxygen Consumption | 2 | 2021 | 696 | 0.050 |
Why?
| | Kinetics | 3 | 1998 | 1670 | 0.050 |
Why?
| | Caspase 3 | 2 | 2002 | 246 | 0.050 |
Why?
| | Models, Cardiovascular | 1 | 2004 | 198 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2024 | 162 | 0.050 |
Why?
| | Respiration | 1 | 2023 | 199 | 0.050 |
Why?
| | Acyl Coenzyme A | 2 | 2013 | 31 | 0.050 |
Why?
| | Cold Temperature | 1 | 2024 | 179 | 0.050 |
Why?
| | Coronary Circulation | 1 | 2003 | 143 | 0.050 |
Why?
| | Protein Kinase C | 1 | 2004 | 261 | 0.050 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2004 | 197 | 0.050 |
Why?
| | Glucose | 2 | 2021 | 1020 | 0.050 |
Why?
| | Hydrogen Peroxide | 2 | 2020 | 328 | 0.050 |
Why?
| | Nervous System Diseases | 1 | 2025 | 266 | 0.050 |
Why?
| | Indomethacin | 1 | 2022 | 81 | 0.050 |
Why?
| | CD40 Antigens | 1 | 2022 | 89 | 0.050 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2024 | 328 | 0.050 |
Why?
| | Interleukin-4 | 1 | 2022 | 216 | 0.050 |
Why?
| | Cell Line | 2 | 2021 | 2847 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2022 | 156 | 0.050 |
Why?
| | Doxycycline | 1 | 2021 | 62 | 0.040 |
Why?
| | Mitochondrial Swelling | 1 | 2000 | 1 | 0.040 |
Why?
| | Phenylephrine | 1 | 2021 | 75 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2020 | 3015 | 0.040 |
Why?
| | Metabolome | 1 | 2024 | 350 | 0.040 |
Why?
| | Myofibrils | 1 | 2021 | 50 | 0.040 |
Why?
| | Sarcomeres | 1 | 2021 | 96 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2004 | 648 | 0.040 |
Why?
| | Culture Media | 1 | 2021 | 165 | 0.040 |
Why?
| | Ruthenium Red | 2 | 2001 | 7 | 0.040 |
Why?
| | Caspase Inhibitors | 1 | 2000 | 81 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2000 | 91 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2022 | 302 | 0.040 |
Why?
| | Spermine | 2 | 2001 | 27 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 327 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2002 | 218 | 0.040 |
Why?
| | Ion Channels | 1 | 2000 | 133 | 0.040 |
Why?
| | Oxidative Phosphorylation | 2 | 2017 | 193 | 0.040 |
Why?
| | Escherichia coli | 1 | 2024 | 815 | 0.040 |
Why?
| | Child, Preschool | 3 | 2021 | 11074 | 0.040 |
Why?
| | Respiratory Function Tests | 1 | 2022 | 600 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 2057 | 0.040 |
Why?
| | Swine | 2 | 2013 | 775 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 558 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2000 | 321 | 0.040 |
Why?
| | Pancreas | 1 | 2021 | 329 | 0.040 |
Why?
| | Metabolomics | 1 | 2024 | 678 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 886 | 0.040 |
Why?
| | Ankle Brachial Index | 1 | 2018 | 37 | 0.040 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 200 | 0.040 |
Why?
| | Fibrosis | 1 | 2021 | 552 | 0.040 |
Why?
| | Organ Size | 2 | 2009 | 477 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 452 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 1999 | 233 | 0.040 |
Why?
| | Isolated Heart Preparation | 1 | 2017 | 6 | 0.040 |
Why?
| | Cellular Microenvironment | 1 | 2018 | 84 | 0.040 |
Why?
| | Lipids | 2 | 2012 | 672 | 0.030 |
Why?
| | Atrial Natriuretic Factor | 2 | 2009 | 57 | 0.030 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 266 | 0.030 |
Why?
| | Aged | 3 | 2018 | 23961 | 0.030 |
Why?
| | Insulin | 2 | 2021 | 2409 | 0.030 |
Why?
| | Enzymes | 1 | 2017 | 67 | 0.030 |
Why?
| | Protein Binding | 2 | 2012 | 2224 | 0.030 |
Why?
| | Myosin Heavy Chains | 2 | 2009 | 192 | 0.030 |
Why?
| | Lipogenesis | 1 | 2016 | 61 | 0.030 |
Why?
| | Adiposity | 1 | 2021 | 518 | 0.030 |
Why?
| | Myocardial Infarction | 1 | 2003 | 1046 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2021 | 860 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 2 | 2008 | 889 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1738 | 0.030 |
Why?
| | Hepatocytes | 1 | 2016 | 220 | 0.030 |
Why?
| | Calcium Channels | 3 | 2001 | 159 | 0.030 |
Why?
| | Middle Aged | 3 | 2018 | 33479 | 0.030 |
Why?
| | Herpesvirus 4, Human | 1 | 2016 | 166 | 0.030 |
Why?
| | Adult | 3 | 2022 | 37929 | 0.030 |
Why?
| | Child | 3 | 2021 | 21935 | 0.030 |
Why?
| | Hypoxia | 1 | 2022 | 1112 | 0.030 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2016 | 98 | 0.030 |
Why?
| | Egtazic Acid | 1 | 1994 | 40 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2021 | 605 | 0.030 |
Why?
| | Infant | 2 | 2021 | 9465 | 0.030 |
Why?
| | Atherosclerosis | 1 | 2018 | 415 | 0.030 |
Why?
| | Age Factors | 2 | 2014 | 3295 | 0.030 |
Why?
| | Automation | 1 | 1994 | 95 | 0.030 |
Why?
| | DNA | 1 | 2001 | 1459 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3556 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1774 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1783 | 0.030 |
Why?
| | Ventricular Function, Left | 2 | 2009 | 534 | 0.030 |
Why?
| | Cytochrome Reductases | 1 | 2012 | 3 | 0.030 |
Why?
| | Palmitoyl Coenzyme A | 1 | 2012 | 2 | 0.030 |
Why?
| | Phospholipases | 1 | 2012 | 14 | 0.030 |
Why?
| | Proteolipids | 1 | 2012 | 31 | 0.030 |
Why?
| | Ubiquinone | 1 | 2012 | 29 | 0.020 |
Why?
| | Swine, Miniature | 1 | 2013 | 82 | 0.020 |
Why?
| | Weight Gain | 1 | 2016 | 519 | 0.020 |
Why?
| | Thyroxine | 1 | 2012 | 62 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2012 | 443 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2012 | 128 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2012 | 343 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2012 | 372 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2011 | 82 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2014 | 6079 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2012 | 570 | 0.020 |
Why?
| | Species Specificity | 1 | 2012 | 585 | 0.020 |
Why?
| | Cholesterol | 1 | 2013 | 410 | 0.020 |
Why?
| | RNA Interference | 1 | 2012 | 469 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 320 | 0.020 |
Why?
| | Models, Chemical | 1 | 2012 | 263 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2012 | 476 | 0.020 |
Why?
| | Superoxide Dismutase | 2 | 2003 | 346 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 3958 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2012 | 665 | 0.020 |
Why?
| | Thromboxane B2 | 1 | 2009 | 26 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 861 | 0.020 |
Why?
| | Constriction | 1 | 2009 | 47 | 0.020 |
Why?
| | Aorta, Abdominal | 1 | 2009 | 46 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 976 | 0.020 |
Why?
| | Arachidonic Acid | 1 | 2009 | 120 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 21513 | 0.020 |
Why?
| | Thromboxanes | 1 | 2008 | 17 | 0.020 |
Why?
| | Cytochromes c | 1 | 2008 | 60 | 0.020 |
Why?
| | Rats, Mutant Strains | 1 | 2008 | 25 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4149 | 0.020 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2011 | 446 | 0.020 |
Why?
| | Hemodynamics | 1 | 2013 | 1113 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2012 | 2139 | 0.020 |
Why?
| | Phosphorylation | 1 | 2013 | 1759 | 0.020 |
Why?
| | Diet, Fat-Restricted | 1 | 2008 | 79 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 2900 | 0.020 |
Why?
| | Heart Transplantation | 1 | 2014 | 754 | 0.020 |
Why?
| | Dietary Carbohydrates | 1 | 2008 | 155 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5472 | 0.020 |
Why?
| | Cell Death | 1 | 2008 | 374 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 7635 | 0.020 |
Why?
| | Cytokines | 1 | 2013 | 2085 | 0.010 |
Why?
| | Isomerism | 1 | 2005 | 56 | 0.010 |
Why?
| | Pulmonary Artery | 1 | 2011 | 1086 | 0.010 |
Why?
| | Cell Size | 1 | 2005 | 91 | 0.010 |
Why?
| | Proteinuria | 1 | 2005 | 97 | 0.010 |
Why?
| | RNA | 1 | 2011 | 921 | 0.010 |
Why?
| | Cell Separation | 1 | 2005 | 318 | 0.010 |
Why?
| | Exercise Test | 1 | 2007 | 625 | 0.010 |
Why?
| | Leptin | 1 | 2005 | 236 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2012 | 2607 | 0.010 |
Why?
| | Blood Glucose | 1 | 2013 | 2186 | 0.010 |
Why?
| | Ditiocarb | 1 | 2002 | 3 | 0.010 |
Why?
| | Fluoresceins | 1 | 2002 | 47 | 0.010 |
Why?
| | Survival Analysis | 1 | 2005 | 1325 | 0.010 |
Why?
| | Tibia | 1 | 2003 | 178 | 0.010 |
Why?
| | Chelating Agents | 1 | 2002 | 75 | 0.010 |
Why?
| | Calcium Radioisotopes | 1 | 2001 | 2 | 0.010 |
Why?
| | Adenylate Kinase | 1 | 2001 | 26 | 0.010 |
Why?
| | Adenosine Diphosphate | 1 | 2001 | 79 | 0.010 |
Why?
| | Chickens | 1 | 2001 | 191 | 0.010 |
Why?
| | Adenosine Monophosphate | 1 | 2001 | 66 | 0.010 |
Why?
| | Sodium | 1 | 2000 | 217 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2003 | 752 | 0.010 |
Why?
| | Electric Conductivity | 1 | 1998 | 86 | 0.010 |
Why?
| | NF-kappa B | 1 | 2002 | 691 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2002 | 915 | 0.010 |
Why?
| | Proteins | 1 | 2002 | 1009 | 0.010 |
Why?
| | Brain | 1 | 1998 | 2668 | 0.000 |
Why?
|
|
Sparagna's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|